Please note that we have stopped the regular imports of Gene Expression Omnibus (GEO) data into ArrayExpress. This may not be the latest version of this experiment.

E-GEOD-42763 - Expression data of multiple sclerosis patients receiving glatiramer acetate therapy [U133 Plus 2.0]

Status
Released on 7 December 2012, last updated on 14 January 2013
Organism
Homo sapiens
Samples (37)
Array (1)
Protocols (8)
Description
The purpose of this study was to analyze the transcriptional effects induced by glatiramer acetate treatment (GA; Copaxone, 20 mg injected subcutaneously once daily) in blood monocytes of patients with relapsing-remitting form of multiple sclerosis (MS). By using Affymetrix DNA microarrays, we obtained genome-wide expression profiles of monocytes from 8 MS patients within the first two months of GA administration. EDTA blood samples were taken from all patients immediately before first and second GA injection as well as after 1 week, 1 month and 2 months. Total RNA of CD14+ monocytes isolated by magnetic-activated cell sorting (MACS) from each sample was extracted, labeled and hybridized to Affymetrix Human Genome U133 Plus 2.0 arrays to quantify the mRNA levels. This GEO entry provides the U133 Plus 2.0 microarray data.
Experiment type
transcription profiling by array 
Contacts
Dirk Koczan, Michael Hecker, Robert H Goertsches, Uwe K Zettl
MIAME
PlatformsProtocolsVariablesProcessedRaw
Files
Investigation descriptionE-GEOD-42763.idf.txt
Sample and data relationshipE-GEOD-42763.sdrf.txt
Raw data (1)E-GEOD-42763.raw.1.zip
Processed data (1)E-GEOD-42763.processed.1.zip
Array designA-GEOD-14837.adf.txt
Links